Nanjing Zaiming Pharmaceutical Co., Ltd.
PrivateLast Round
Series A
Jun 1, 2025
Est. Valuation
$1.19B
Total Funding Raised
$149M
Company Overview
Nanjing Zaiming Pharmaceutical Co., Ltd. is a pharmaceutical company that focuses on the research and development of innovative oncology therapies, including WRN inhibitors and antibody-based treatments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nanjing Zaiming Pharmaceutical Co., Ltd. Comparables
Compare Nanjing Zaiming Pharmaceutical Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Innovent Biologics | 78% | |
| CStone Pharmaceuticals | 77% | |
| Zai Lab Limited | 74% |
Nanjing Zaiming Pharmaceutical Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 1, 2025 |
Nanjing Zaiming Pharmaceutical Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Zhonghe Capital | Series A |
| Apricot Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2025
$149M round led by Advanced Manufacturing Industry Investment Fund II.
Nanjing Zaiming Pharmaceutical Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nanjing Zaiming Pharmaceutical Co., Ltd.'s valuation, stock price, and market status.
Is Nanjing Zaiming Pharmaceutical Co., Ltd. a public or private company?
Nanjing Zaiming Pharmaceutical Co., Ltd. is a private company.
What is the current stock price of Nanjing Zaiming Pharmaceutical Co., Ltd.?
Nanjing Zaiming Pharmaceutical Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is Nanjing Zaiming Pharmaceutical Co., Ltd. worth (valuation)?
Nanjing Zaiming Pharmaceutical Co., Ltd.'s valuation is estimated at $1.2B based on funding round data.
Can I buy Nanjing Zaiming Pharmaceutical Co., Ltd. stock?
Nanjing Zaiming Pharmaceutical Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Nanjing Zaiming Pharmaceutical Co., Ltd.'s last funding round?
Nanjing Zaiming Pharmaceutical Co., Ltd.'s most recent funding round was Series A on June 1, 2025.
Who are the main investors in Nanjing Zaiming Pharmaceutical Co., Ltd.?
Key investors in Nanjing Zaiming Pharmaceutical Co., Ltd. include Zhonghe Capital, Apricot Capital.
Will Nanjing Zaiming Pharmaceutical Co., Ltd. IPO soon?
No public IPO plans have been announced for Nanjing Zaiming Pharmaceutical Co., Ltd..
How can I track Nanjing Zaiming Pharmaceutical Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nanjing Zaiming Pharmaceutical Co., Ltd.'s secondary market activity and sign up for updates.